Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Keratinocyte-Specific Ablation of RIPK4 Allows Epidermal Cornification but Impairs Skin Barrier Formation.

Urwyler-Rösselet C, Tanghe G, Leurs K, Gilbert B, De Rycke R, De Bruyne M, Lippens S, Bartunkova S, De Groote P, Niessen C, Haftek M, Vandenabeele P, Declercq W.

J Invest Dermatol. 2018 Jun;138(6):1268-1278. doi: 10.1016/j.jid.2017.12.031. Epub 2018 Jan 6.

2.

Developing 3D SEM in a broad biological context.

Kremer A, Lippens S, Bartunkova S, Asselbergh B, Blanpain C, Fendrych M, Goossens A, Holt M, Janssens S, Krols M, Larsimont JC, Mc Guire C, Nowack MK, Saelens X, Schertel A, Schepens B, Slezak M, Timmerman V, Theunis C, VAN Brempt R, Visser Y, Guérin CJ.

J Microsc. 2015 Aug;259(2):80-96. doi: 10.1111/jmi.12211. Epub 2015 Jan 26.

3.

ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling.

Goossens S, Radaelli E, Blanchet O, Durinck K, Van der Meulen J, Peirs S, Taghon T, Tremblay CS, Costa M, Farhang Ghahremani M, De Medts J, Bartunkova S, Haigh K, Schwab C, Farla N, Pieters T, Matthijssens F, Van Roy N, Best JA, Deswarte K, Bogaert P, Carmichael C, Rickard A, Suryani S, Bracken LS, Alserihi R, Canté-Barrett K, Haenebalcke L, Clappier E, Rondou P, Slowicka K, Huylebroeck D, Goldrath AW, Janzen V, McCormack MP, Lock RB, Curtis DJ, Harrison C, Berx G, Speleman F, Meijerink JP, Soulier J, Van Vlierberghe P, Haigh JJ.

Nat Commun. 2015 Jan 7;6:5794. doi: 10.1038/ncomms6794.

4.

Loss of autocrine endothelial-derived VEGF significantly reduces hemangiosarcoma development in conditional p53-deficient mice.

Farhang Ghahremani M, Radaelli E, Haigh K, Bartunkova S, Haenebalcke L, Marine JC, Goossens S, Haigh JJ.

Cell Cycle. 2014;13(9):1501-7. doi: 10.4161/cc.28474. Epub 2014 Mar 11.

5.

Efficient ROSA26-based conditional and/or inducible transgenesis using RMCE-compatible F1 hybrid mouse embryonic stem cells.

Haenebalcke L, Goossens S, Naessens M, Kruse N, Farhang Ghahremani M, Bartunkova S, Haigh K, Pieters T, Dierickx P, Drogat B, Nyabi O, Wirth D, Haigh JJ.

Stem Cell Rev Rep. 2013 Dec;9(6):774-85. doi: 10.1007/s12015-013-9458-z.

PMID:
23877658
6.

Beta-Actin Is Involved in Modulating Erythropoiesis during Development by Fine-Tuning Gata2 Expression Levels.

Tondeleir D, Drogat B, Slowicka K, Bakkali K, Bartunkova S, Goossens S, Haigh JJ, Ampe C.

PLoS One. 2013 Jun 26;8(6):e67855. doi: 10.1371/journal.pone.0067855. Print 2013.

7.

p53 promotes VEGF expression and angiogenesis in the absence of an intact p21-Rb pathway.

Farhang Ghahremani M, Goossens S, Nittner D, Bisteau X, Bartunkova S, Zwolinska A, Hulpiau P, Haigh K, Haenebalcke L, Drogat B, Jochemsen A, Roger PP, Marine JC, Haigh JJ.

Cell Death Differ. 2013 Jul;20(7):888-97. doi: 10.1038/cdd.2013.12. Epub 2013 Mar 1.

8.

The ROSA26-iPSC mouse: a conditional, inducible, and exchangeable resource for studying cellular (De)differentiation.

Haenebalcke L, Goossens S, Dierickx P, Bartunkova S, D'Hont J, Haigh K, Hochepied T, Wirth D, Nagy A, Haigh JJ.

Cell Rep. 2013 Feb 21;3(2):335-41. doi: 10.1016/j.celrep.2013.01.016. Epub 2013 Feb 7.

9.

The EMT regulator Zeb2/Sip1 is essential for murine embryonic hematopoietic stem/progenitor cell differentiation and mobilization.

Goossens S, Janzen V, Bartunkova S, Yokomizo T, Drogat B, Crisan M, Haigh K, Seuntjens E, Umans L, Riedt T, Bogaert P, Haenebalcke L, Berx G, Dzierzak E, Huylebroeck D, Haigh JJ.

Blood. 2011 May 26;117(21):5620-30. doi: 10.1182/blood-2010-08-300236. Epub 2011 Feb 25.

PMID:
21355089
10.

Vegf regulates embryonic erythroid development through Gata1 modulation.

Drogat B, Kalucka J, Gutiérrez L, Hammad H, Goossens S, Farhang Ghahremani M, Bartunkova S, Haigh K, Deswarte K, Nyabi O, Naessens M, Ferrara N, Klingmüller U, Lambrecht BN, Nagy A, Philipsen S, Haigh JJ.

Blood. 2010 Sep 23;116(12):2141-51. doi: 10.1182/blood-2010-01-264143. Epub 2010 Jun 16.

PMID:
20554972
11.

Increased skeletal VEGF enhances beta-catenin activity and results in excessively ossified bones.

Maes C, Goossens S, Bartunkova S, Drogat B, Coenegrachts L, Stockmans I, Moermans K, Nyabi O, Haigh K, Naessens M, Haenebalcke L, Tuckermann JP, Tjwa M, Carmeliet P, Mandic V, David JP, Behrens A, Nagy A, Carmeliet G, Haigh JJ.

EMBO J. 2010 Jan 20;29(2):424-41. doi: 10.1038/emboj.2009.361. Epub 2009 Dec 10.

12.

Efficient mouse transgenesis using Gateway-compatible ROSA26 locus targeting vectors and F1 hybrid ES cells.

Nyabi O, Naessens M, Haigh K, Gembarska A, Goossens S, Maetens M, De Clercq S, Drogat B, Haenebalcke L, Bartunkova S, De Vos I, De Craene B, Karimi M, Berx G, Nagy A, Hilson P, Marine JC, Haigh JJ.

Nucleic Acids Res. 2009 Apr;37(7):e55. doi: 10.1093/nar/gkp112. Epub 2009 Mar 11.

13.

[Children in the risk of metabolic syndrome].

Bartůnková S.

Cas Lek Cesk. 2009;148(12):584-90. Review. Czech.

PMID:
20662393
14.

Analysis of embryonic vascular morphogenesis.

Sato TN, Bartunkova S.

Methods Mol Biol. 2000;137:223-33. No abstract available.

PMID:
10948541
15.

The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development.

Tanaka M, Chen Z, Bartunkova S, Yamasaki N, Izumo S.

Development. 1999 Mar;126(6):1269-80.

16.

Vertebrate homologs of tinman and bagpipe: roles of the homeobox genes in cardiovascular development.

Tanaka M, Kasahara H, Bartunkova S, Schinke M, Komuro I, Inagaki H, Lee Y, Lyons GE, Izumo S.

Dev Genet. 1998;22(3):239-49.

PMID:
9621431
17.

Cardiac and extracardiac expression of Csx/Nkx2.5 homeodomain protein.

Kasahara H, Bartunkova S, Schinke M, Tanaka M, Izumo S.

Circ Res. 1998 May 18;82(9):936-46.

PMID:
9598591
18.

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.

Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD.

Science. 1997 Jul 4;277(5322):55-60.

19.

Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice.

Schlaeger TM, Bartunkova S, Lawitts JA, Teichmann G, Risau W, Deutsch U, Sato TN.

Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3058-63.

20.

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis.

Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD.

Cell. 1996 Dec 27;87(7):1171-80.

21.

An attempt to intervene combined risk score by increased physical activity.

Bartůnková S.

Act Nerv Super (Praha). 1982;Suppl 3(Pt 2):466-9.

PMID:
6190344
22.

[Sex differences in functional indices of selected samples of 12-55-year-old population in Czechoslovakia].

Havlícková L, Seliger V, Bartůnĕk Z, Bartůnková S, Pauer M, Vránová J.

Cas Lek Cesk. 1981 Sep 17;120(37):1108-13. Czech. No abstract available.

PMID:
7273080
23.

[Adaptation changes in cardiovascular training in men aged 40--55 years (author's transl)].

Bartůnková S, Pospísilová M, Bartůnĕk Z, Seliger V, Melichna J, Havlícková L.

Cas Lek Cesk. 1978 Sep 29;117(38-39):1209-14. Czech. No abstract available.

PMID:
709596
24.

The habitual activity and physical fitness of 12 year old boys.

Seliger V, Trefny Z, Bartunková S, Pauer M.

Acta Paediatr Belg. 1974;28 suppl:54-9. No abstract available.

PMID:
4446993
25.

Relationships between the quantitative ballistocardiographic characteristics and the functional indices at graduated work load.

Trefný Z, Saliger V, Bartůnková S.

Bibl Cardiol. 1973;32:115-9. No abstract available.

PMID:
4750730

Supplemental Content

Loading ...
Support Center